Trio of Acquisitions to Reinforce Edwards Lifesciences Heart Portfolio

Last month (July 2024) Edwards Lifesciences announced it is to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic … continue reading "Trio of Acquisitions to Reinforce Edwards Lifesciences Heart Portfolio"

The post Trio of Acquisitions to Reinforce Edwards Lifesciences Heart Portfolio appeared first on Medlatest - Medical Device News.